PAPP-A as a Marker of Increased Long-Term Risk in Patients With Chest Pain

Clinical Biochemistry - Netherlands
doi 10.1016/j.clinbiochem.2009.03.015
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Absence of Chest Pain and Long-Term Mortality in Patients With Acute Myocardial Infarction

Open Heart
Cardiovascular MedicineCardiology
2018English

Renal Dysfunction as a Marker of Increased Mortality in Patients With Pulmonary Thromboembolism

Anatolian journal of cardiology
Cardiovascular MedicineCardiology
2016English

Postextrasystolic "T Wave Hump" Augmentation as a Marker of Increased Arrhythmogenic Risk in the Long QT Syndrome

Heart
2002English

Carotid Artery Disease as a Marker for the Presence of Severe Coronary Artery Disease in Patients Evaluated for Chest Pain

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
1999English

Efficacy of Fasting Glucose-Leptin Ratio as a Risk Marker for Development of Long Term Diabetic Complications

International Journal of Clinical Chemistry and Laboratory Medicine
2019English

Hypnotherapy for Non-Cardiac Chest Pain: Long-Term Follow-Up

Gut
Gastroenterology
2007English

Self-Harm Thoughts Postpartum as a Marker for Long-Term Morbidity

Frontiers in Public Health
EnvironmentalPublic HealthOccupational Health
2018English

Cost-Effectiveness of Telemetry for Hospitalized Patients With Low-Risk Chest Pain

Academic Emergency Medicine
MedicineEmergency Medicine
2011English

Erectile Dysfunction: A Marker of Increased Cardiovascular Risk

Hypertension
Internal Medicine
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy